SCHEMBL4602238

SCHEMBL4602238

O=S(=O)(Cl)C(F)C(F)CCF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4616730 0.79
SCHEMBL216635 0.75
SCHEMBL19857238 0.75
SCHEMBL20502431 0.74
SCHEMBL28807959 0.73
Potassium Ion SCHEMBL28620111 0.73
SCHEMBL4466499 0.70
SCHEMBL1660641 0.66
SCHEMBL20502529 0.65
SCHEMBL6666076 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117043143-A Substituted 2- (heteroaryloxyphenyl) sulfonates, salts thereof and their use as herbicides 拜耳公司 2023-11-10 CN disclosed
CN-116348455-A Protein tyrosine phosphatase inhibitors and methods of use thereof 卡里科生命科学有限责任公司 2023-06-27 CN disclosed
CN-1918129-B Therapeutic agents ASTRAZENECA AB 2011-06-15 CN disclosed
CN-101282963-A Pyrazole derivatives as therapeutic agents ASTRAZENECA AB (SE) 2008-10-08 CN disclosed
EP-1940803-A1 1,2-DIARYLIMIDAZOLES FOR USE AS CBI MODULATORS AstraZeneca AB (SE) 2008-07-09 EP disclosed
EP-1915364-A1 PYRAZOLE DERIVATIVES AS THERAPEUTIC AGENTS AstraZeneca AB (SE) 2008-04-30 EP disclosed
CN-1964948-A Therapeutic agents ASTRAZENECA AB (SE) 2007-05-16 CN disclosed
WO-2007031720-A1 1,2-DIARYLIMIDAZOLES FOR USE AS CBI MODULATORS ASTRAZENECA AB (SE) 2007-03-22 WO disclosed
WO-2007020388-A1 PYRAZOLE DERIVATIVES AS THERAPEUTIC AGENTS ASTRAZENECA AB (SE) 2007-02-22 WO disclosed
CN-1918129-A Therapeutic agents ASTRAZENECA AB (SE) 2007-02-21 CN disclosed